Sp1 regulates TPX2 expression, resulting in a cascade effect, in EC; it affects the malignant progression of endometrial cancer cells by coupling the CX3CR1/CXCL10 chemokine pathway to the PI3K/Akt signaling pathway. Here, CXCL10 is linked to endometrial cancer.